Stephanie Okey - Insider Trading & Ownership

Location
C/O Albireo Pharma, Inc., 10 Post Office Square, Suite 502 South, Boston, MA
Summary
The estimated net worth of Stephanie Okey is at least $1.31M dollars as of November 21, 2025. Stephanie Okey is the Director of PTC THERAPEUTICS, INC. and owns shares of PTC THERAPEUTICS, INC. (PTCT) stock worth about $769K. Stephanie Okey is the Director of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $543K.
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Stephanie Okey

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PTCT PTC THERAPEUTICS, INC. Director $769K -$270K -26% Nov 20, 2025
CRNX Crinetics Pharmaceuticals, Inc. Director $543K Jun 11, 2025
CTLT Catalent, Inc. Director $0 Dec 18, 2024
ALBO ALBIREO PHARMA, INC. Director Mar 2, 2023

Insider Transactions Reported by Stephanie Okey:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.